&quot;The Readout LOUD&quot; is going international this week.<br><br>STAT&#x27;s Jason Mast joins the podcast from Shanghai, where he&#x27;s digging into what the rise of Chinese drug development means for the biotech industry. The hosts also speak to colleague Margaret Manto about Heidi Overton, the president&#x27;s pick to be commissioner of the Food and Drug Administration. Will the new nominee bring some needed stability or controversy to the troubled agency?<br><br>For more on Overton and her views on China, go here; to read about the ITM and Telix merger, go here; you can find the latest news on osteoporosis here.

The FDA's Overton era, and dispatches from Shanghai

The Readout Loud

[SPEAKER_04] Welcome to The Readout Loud, a weekly biotech podcast from STAT. I'm Allison DeAngelis.

[SPEAKER_00] I'm Adam Forrestine.

[SPEAKER_04] And I'm Elaine Chen. After a turbulent 18 months for the FDA, will a new nominee to lead the troubled agency bring more stability or controversy?

[SPEAKER_02] If I have the privilege of being confirmed, I will work with the dedicated career professionals to make sure every aspect of clinical trials and drug development is optimized. This will not only bring development back to the United States, it will bring cures to patients faster. If confirmed, I will work to ensure every talented person at the agency shares the goal of making the FDA the agency of the possible rather than the impossible.

[SPEAKER_04] We take a look at Heidi Overton and what her tenure may mean for the future of the FDA.

[SPEAKER_00] And our colleague Jason Mass spent the last week in Shanghai attending a biotech investing conference. We'll chat with him about the rise of Chinese biotech.

[SPEAKER_03] All that and the latest biotech news after a word from our sponsor.

[SPEAKER_00] Allison, on a scale of 1 to 10, how excited are you that The Great British Baking Show starts this week?

[SPEAKER_04] I'm about at a 7. It hasn't sunk in yet that it's starting, but I'm getting excited. How are you feeling?

[SPEAKER_00] I'm at like a 9, mostly because I hope in the first episode, Nigella Lawson, who is one of the new co-hosts of the show this season, like somehow they work in the micro-wave reference.

[SPEAKER_03] I have no idea what you're talking about.

[SPEAKER_04] Oh, yes. You know who's at a 10 out of 10 for excitement? Elaine Chen. Never been more excited in my life.

The FDA's Overton era, and dispatches from Shanghai

Read the full transcript

The candid version is on a podcast,
not the earnings call.

The FDA's Overton era, and dispatches from Shanghai

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.